Viewing StudyNCT03315039



Ignite Creation Date: 2024-05-06 @ 10:38 AM
Last Modification Date: 2024-10-26 @ 12:33 PM
Study NCT ID: NCT03315039
Status: COMPLETED
Last Update Posted: 2022-03-10
First Post: 2017-10-16

Brief Title: Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia AML
Sponsor: Moleculin Biotech Inc
Organization: Moleculin Biotech Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-03-28
Start Date Type: ACTUAL
Primary Completion Date: 2020-01-14
Primary Completion Date Type: ACTUAL
Completion Date: 2020-06-20
Completion Date Type: ACTUAL
First Submit Date: 2017-10-16
First Submit QC Date: October 18 2017
Study First Post Date: 2017-10-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2022-02-23
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-02-28
Last Update Post Date: 2022-03-10
Last Update Post Date Type: ACTUAL